Loading...
By Kelly Young
Edited by Jaye Elizabeth Hefner, MD
Canadian patients with cystic fibrosis have a survival advantage over their U.S. counterparts, according to a study in the Annals of Internal Medicine.
Using national registry data, researchers followed some 45,000 U.S. patients and 6000 Canadian patients with cystic fibrosis. Beginning in 2009, the median age of survival was significantly higher among Canadians (50.9 years vs. 40.6 years). In addition, a higher proportion of Canadian patients had received organ transplants (10.3% vs. 6.5%).
The authors say their work suggests that higher transplantation rates in Canada "may be contributing to the observed survival gap."
Editorialists conclude: "Now comes the harder work of trying to identify and implement solutions to bridge this survival gap, which appear[s] to be based on fundamental differences in the two nations' healthcare systems."
Comment
LINK(S):
Annals of Internal Medicine article (Free abstract)
Background: NEJM Journal Watch General Medicine coverage of lengthening survival for patients with CF (Your NEJM Journal Watch registration required)